Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $15.1000 (6.75%) ($15.1000 - $15.1000) on Mon. Aug. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.7% (three month average) | RSI | 43 | Latest Price | $15.1000(6.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.3% a day on average for past five trading days. | Weekly Trend | BCRX declines -8.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(38%) ARKK(37%) SKYY(36%) | Factors Impacting BCRX price | BCRX will decline at least -1.85% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-7%) TBT(-3%) IGOV(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.85% (StdDev 3.7%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.86(-87.68%) | Resistance Level | $15.94 | 5 Day Moving Average | $14.49(4.21%) | 10 Day Moving Average | $15.1(0%) | 20 Day Moving Average | $15.94(-5.27%) | To recent high | -14.6% | To recent low | 13.7% | Market Cap | $2.664b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |